301267 华厦眼科
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)5.4627.9657.48712.36414.789
总资产报酬率 ROA (%)3.8065.6935.6029.43610.322
投入资产回报率 ROIC (%)4.4216.5346.36310.51311.743

边际利润分析
销售毛利率 (%)44.11743.30844.19349.03248.048
营业利润率 (%)18.26814.87216.00324.25522.499
息税前利润/营业总收入 (%)19.03015.01014.85621.78621.196
净利润/营业总收入 (%)13.88610.46210.63416.88015.749

收益指标分析
经营活动净收益/利润总额(%)93.51799.770101.769101.713106.303
价值变动净收益/利润总额(%)5.4266.50111.67710.2372.219
营业外收支净额/利润总额(%)-2.068-7.282-14.433-13.939-11.296

偿债能力分析
流动比率 (X)3.5403.8434.6494.8755.847
速动比率 (X)3.3923.6904.4934.6685.648
资产负债率 (%)28.06727.83423.98522.51323.841
带息债务/全部投入资本 (%)7.1187.4603.7303.9863.483
股东权益/带息债务 (%)1,145.9331,076.3022,243.9822,166.1872,400.087
股东权益/负债合计 (%)248.050250.609304.875340.438318.601
利息保障倍数 (X)16.81313.08517.06143.69921.621

营运能力分析
应收账款周转天数 (天)26.15526.28927.22223.25121.332
存货周转天数 (天)27.39125.76929.47632.05730.325